RecruitingNCT06563414

A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)

Sponsor

Krystal Biotech, Inc.

Enrollment

40 participants

Start Date

Aug 2, 2024

Study Type

OBSERVATIONAL

Conditions

Epidermolysis Bullosa Dystrophica Epidermolysis Bullosa Dystrophica, Recessive Epidermolysis Bullosa Dystrophica Dominans

Summary

This study is a non-interventional, observational study that will evaluate the natural history of corneal abrasions in patients with Dystrophic Epidermolysis Bullosa (DEB).

Eligibility

Min Age: 6 Months

Inclusion Criteria3

The subject or their respective legal guardian must have read, understood, and signed an Institutional Review Board (IRB) approved Informed Consent/Assent Form and must be able to and willing to follow study procedures and instructions.
Age 6 months or older at time of Informed Consent/Assent.
Prior genetic diagnosis of DEB due to mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene.

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Krystal Biotech

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06563414

Related Trials

Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa

NCT010191481 location

Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro

NCT061773532 locations